<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.__)*
NURESCELL INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.0001 PER SHARE
(Title of Class of Securities)
67057R 101
(CUSIP Number)
July 25, 2000
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/ / Rule 13d-1(b)
/X/ Rule 13d-1(c)
/ / Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 5 Pages
<PAGE>
CUSIP No. 67057R 101 13G Page 2 of 5 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Triton Private Equities Fund, L.P.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 0 shares
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 0 shares
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0 shares
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 0 shares
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 shares
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[X]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 2 of 5 Pages
<PAGE>
ITEM 1.
(a) Name of Issuer
Nurescell Inc.
--------------------------------------------------------------------
(b) Address of Issuer's Principal Executive Offices
1400 Bristol Street North, Suite 240
Newport Beach, California 92660
--------------------------------------------------------------------
ITEM 2.
(a) Name of Person Filing
Triton Private Equities Fund, L.P.
--------------------------------------------------------------------
(b) Address of Principal Business Office or, if none, Residence
220 Executive Center, 225 North Market Street
Wichita, Kansas 67202
--------------------------------------------------------------------
(c) Citizenship
Delaware
--------------------------------------------------------------------
(d) Title of Class of Securities
Common Stock, par value $0.0001 per share
--------------------------------------------------------------------
(e) CUSIP Number
67057R 101
--------------------------------------------------------------------
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTIONS 240.13d-1(b) OR
240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:
Not Applicable
ITEM 4. OWNERSHIP
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
0 shares*
--------------------------------------------------------------------------
(b) Percent of class:
0%*
--------------------------------------------------------------------------
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote
0 shares*
----------------------------------------------------------------
Page 3 of 5 Pages
<PAGE>
(ii) Shared power to vote or to direct the vote
0 shares
----------------------------------------------------------------
(iii) Sole power to dispose or to direct the disposition of
0 shares*
----------------------------------------------------------------
(iv) Shared power to dispose or to direct the disposition of
0 shares
----------------------------------------------------------------
* Excludes shares obtainable by the reporting person upon the
exercise of outstanding debt conversion rights and warrants, as to which
beneficial ownership is disclaimed due to uncertainty as to the number of shares
which the reporting person may actually acquire as a result of the exercise, if
any, of such rights and warrants.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
NOT APPLICABLE
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
NOT APPLICABLE
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
NOT APPLICABLE
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
NOT APPLICABLE
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
NOT APPLICABLE
ITEM 10. CERTIFICATION
By signing below I certify that,to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
Page 4 of 5 Pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: September 5, 2000 Triton Private Equities Fund, L.P.
By: Triton Capital Management, L.L.C.,
General Partner
By: /s/ JOHN C. TAUSCHE
--------------------------------
John C. Tausche, Managing Member
Page 5 of 5 Pages
